Compare Heron Therapeutics Inc (HRTX) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Packaging Corporation of America — how do they compare? Heron Therapeutics Inc trades at $0.41 (market cap $68.01M), while Packaging Corporation of America trades at $230.51 (market cap $20.49B). The key difference: Packaging Corporation of America is far larger — about 301.3× Heron Therapeutics Inc's market cap, and Packaging Corporation of America pays a 2.61% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Packaging Corporation of America for 45 Days on average.
| HRTX | PKG | |
|---|---|---|
Market Cap | $68.01M | $20.49B |
Volume | 1,891,941 | 493,499 |
Sector | Health | Consumer Cyclical |
52-Week High | $1.49 | $257.43 |
52-Week Low | $0.27 | $191.68 |
Typical Hold Time | 35 Days | 45 Days |
Enterprise Value | $174.75M | $24.30B |
Dividend Yield | — | 2.61% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.3582, down 8.15% today, with a bullish technical signal from moving averages but mixed earnings. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates, continuing a trend of net losses. Analyst sentiment remains strongly positive with 89% buy ratings, though Zacks issued a Strong Sell rating in July 2026.
The outlook hinges on revenue stabilization and path to profitability. Investment opportunity lies in analyst optimism and product sales growth, but risks include persistent losses, high valuation multiples, and competitive pressures in the biotechnology sector.
Packaging Corporation of America (PKG) trades at $229.94, up 1.18% on the day, with a bearish technical signal from moving averages. The company reported mixed quarterly earnings, with Q2 2026 beating estimates but Q4 2025 missing, while revenue grew to $9.5 billion in 2026. Analyst consensus is a Buy with a $272.43 price target, though net cash flow turned negative in 2026.
PKG offers a stable dividend and benefits from consistent packaging demand, but faces margin pressure from rising costs. The stock's valuation appears elevated with a P/E of 29.86, and negative cash flow trends pose a risk. Upside depends on cost management and execution of growth initiatives amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
